CAPA系统诺和诺德.ppt

  1. 1、本文档共33页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
CAPA系统诺和诺德剖析

Slide * 有关CAPA的相关法规 CAPA的重要性 CAPA系统的基本构成元素 涉及的主要内容 总结及问答 Slide no * CAPA系统的构成元素 分析/统计 /风险评估 已发生的或潜在的质量问题 执行行动方案 审核/验证/ 批准 行动方案 调查发生原因 并确定纠正或预防措施 记录并核实 有效性 信息共享和管理层审查 2012 ISPE CHINA ANNUAL CONFERENCE Hongyang Li hoyl@ 谢谢! * To be printed out in 10 pcs. CFR211.192 Production record review: Any unexplained discrepancy (including a percentage of theoretical yield exceeding the maximum or minimum percentages established in master production and control records) or the failure of a batch or any of its components to meet any of its specifications shall be thoroughly investigated, whether or not the batch has already been distributed. The investigation shall extend to other batches of the same drug product and other drug products that may have been associated with the specific failure or discrepancy. A written record of the investigation shall be made and shall include the conclusions and followup EU 1.4: Product Quality Review A review of all significant deviations or non-conformances, their related investigations, and the effectiveness of resultant corrective and preventative actions taken WHO GMP: Annex 4 WHO guidelines on good manufacturing practices for blood establishments 3. Quality management, 3.7 Corrective and preventive actions management of deviations and non-conformances, complaints, events and findings of the quality system management review, inspections and audits Product or quality problems should be entered into the corrective and preventive action system. Quality data include all errors, deviations, non-conformances, accidents, near-miss events and complaints. Quality data also include the results of quality control tests and monitoring activities. ISO9001: 8.5 Improvement, 8.5.2 Corrective Action: a)—f) 8.5.3 Preventive Action: a) – e) ISO13485: 8.5 Improvement, 8.5.2 Corrective action: a)—f) , 8.5.3 Preventive action: a) – e) * * To be printed out in 10 pcs. * To be printed out in 10 pcs. * * * * * To be printed out in 10 pcs. ISPE is the w

文档评论(0)

jiayou10 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:8133070117000003

1亿VIP精品文档

相关文档